+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "ACE Inhibitor"

Anti-Ischemic Agents Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Ischemic Agents Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Acute Coronary Syndrome Market - Global Forecast 2026-2032 - Product Thumbnail Image

Acute Coronary Syndrome Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
From
Zofenopril Calcium Market - Global Forecast 2026-2032 - Product Thumbnail Image

Zofenopril Calcium Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Zhenju Antihypertensive Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Zhenju Antihypertensive Tablets Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
Angina Pectoris Medication Market - Global Forecast 2026-2032 - Product Thumbnail Image

Angina Pectoris Medication Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Cilazapril Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cilazapril Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 199 Pages
  • Global
From
Azelnidipine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Azelnidipine Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
Cardiovascular Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cardiovascular Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Pulmonary Edema Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Edema Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 285 Pages
  • Global
From
From
From
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 155 Pages
  • Global
From
Cardiomyopathy Therapies - Global Strategic Business Report - Product Thumbnail Image

Cardiomyopathy Therapies - Global Strategic Business Report

  • Report
  • October 2026
  • 227 Pages
  • Global
From
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 458 Pages
  • Global
From
Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • October 2026
  • 282 Pages
  • Global
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 587 Pages
  • Global
From
Amlodipine Besylate - Global Strategic Business Report - Product Thumbnail Image

Amlodipine Besylate - Global Strategic Business Report

  • Report
  • October 2026
  • 177 Pages
  • Global
From
Loading Indicator

The ACE Inhibitor market is a segment of the pharmaceutical industry that focuses on drugs used to treat high blood pressure, heart failure, and other cardiovascular diseases. ACE inhibitors are a type of medication that works by blocking the action of an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a hormone called angiotensin II, which can cause blood vessels to narrow and increase blood pressure. By blocking the action of ACE, ACE inhibitors can help reduce blood pressure and improve the symptoms of heart failure. ACE inhibitors are typically prescribed in combination with other medications, such as diuretics, beta-blockers, and calcium channel blockers. They are also used to treat other conditions, such as kidney disease, diabetes, and migraines. Some companies in the ACE Inhibitor market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more